Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Carli

Showing results (41-50 of 51) with videos related to

Pageof 6
Sort By:
BMC Musculoskeletal Disorders|November 3, 2023
Immersive virtual reality for shoulder rehabilitation: evaluation of a physical therapy program executed with oculus quest 2Umile Giuseppe Longo, Arianna Carnevale, Flavia Andreoli, et al.
Current Neuropharmacology|February 24, 2023
Pharmacological Strategies for Bipolar Disorders in Acute Phases and Chronic Management with a Special Focus on Lithium, Valproic Acid, and Atypical AntipsychoticsMarco Carli, Francesco Weiss, Giovanna Grenno, et al.
Pharmaceuticals (Basel, Switzerland)|August 28, 2021
β-Cells Different Vulnerability to the Parkinsonian Neurotoxins Rotenone, 1-Methyl-4-phenylpyridinium (MPP<sup>+</sup>) and 6-Hydroxydopamine (6-OHDA)Marco Carli, Francesca Vaglini, Eleonora Risaliti, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|March 12, 2017
Clozapine as the most efficacious antipsychotic for activating ERK 1/2 kinases: Role of 5-HT<sub>2A</sub> receptor agonismStefano Aringhieri, Shivakumar Kolachalam, Claudio Gerace, et al.
Journal of Clinical Medicine|February 26, 2025
Melanocortin-4 Receptor Antagonism Inhibits Colorectal and Anaplastic Thyroid Cancer In Vitro and In VivoArianna Bandini, Marta Banchi, Paola Orlandi, et al.
Journal of Clinical Medicine|October 29, 2025
Pharmacokinetics and Monitoring of Methotrexate in Adults with Acute Lymphoblastic Leukaemia: A 10-Year Follow-Up at an Italian CentrePasquale Fabio Calabrò, Letizia Biso, Marianna Lastella, et al.
European Journal of Pharmacology|May 11, 2022
Interaction of the preferential D<sub>3</sub> agonist (+)PHNO with dopamine D<sub>3</sub>-D<sub>2</sub> receptor heterodimers and diverse classes of monoamine receptor: relevance for PET imagingFrancesco Petragnano, Irene Fasciani, Clotilde Mannoury la Cour, et al.
Neuroscience|January 20, 2024
In-vitro Approaches to Investigate the Detrimental Effect of Light on Dopaminergic NeuronsIrene Fasciani, Francesco Petragnano, Federica Bono, et al.
Biochemical Pharmacology|November 30, 2023
Melanocortin receptor 4 as a new target in melanoma therapy: Anticancer activity of the inhibitor ML00253764 alone and in association with B-raf inhibitor vemurafenibPaola Orlandi, Marta Banchi, Francesca Vaglini, et al.
Journal of Ethnobiology and Ethnomedicine|May 8, 2007
The importance of a taste. A comparative study on wild food plant consumption in twenty-one local communities in ItalyMaria Pia Ghirardini, Marco Carli, Nicola del Vecchio, et al.
Pageof 6

Showing results (41-50 of 51) with videos related to

Sort By:
Pageof 6
BMC Musculoskeletal Disorders|November 3, 2023
Immersive virtual reality for shoulder rehabilitation: evaluation of a physical therapy program executed with oculus quest 2Umile Giuseppe Longo, Arianna Carnevale, Flavia Andreoli, et al.
Current Neuropharmacology|February 24, 2023
Pharmacological Strategies for Bipolar Disorders in Acute Phases and Chronic Management with a Special Focus on Lithium, Valproic Acid, and Atypical AntipsychoticsMarco Carli, Francesco Weiss, Giovanna Grenno, et al.
Pharmaceuticals (Basel, Switzerland)|August 28, 2021
β-Cells Different Vulnerability to the Parkinsonian Neurotoxins Rotenone, 1-Methyl-4-phenylpyridinium (MPP<sup>+</sup>) and 6-Hydroxydopamine (6-OHDA)Marco Carli, Francesca Vaglini, Eleonora Risaliti, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|March 12, 2017
Clozapine as the most efficacious antipsychotic for activating ERK 1/2 kinases: Role of 5-HT<sub>2A</sub> receptor agonismStefano Aringhieri, Shivakumar Kolachalam, Claudio Gerace, et al.
Journal of Clinical Medicine|February 26, 2025
Melanocortin-4 Receptor Antagonism Inhibits Colorectal and Anaplastic Thyroid Cancer In Vitro and In VivoArianna Bandini, Marta Banchi, Paola Orlandi, et al.
Journal of Clinical Medicine|October 29, 2025
Pharmacokinetics and Monitoring of Methotrexate in Adults with Acute Lymphoblastic Leukaemia: A 10-Year Follow-Up at an Italian CentrePasquale Fabio Calabrò, Letizia Biso, Marianna Lastella, et al.
European Journal of Pharmacology|May 11, 2022
Interaction of the preferential D<sub>3</sub> agonist (+)PHNO with dopamine D<sub>3</sub>-D<sub>2</sub> receptor heterodimers and diverse classes of monoamine receptor: relevance for PET imagingFrancesco Petragnano, Irene Fasciani, Clotilde Mannoury la Cour, et al.
Neuroscience|January 20, 2024
In-vitro Approaches to Investigate the Detrimental Effect of Light on Dopaminergic NeuronsIrene Fasciani, Francesco Petragnano, Federica Bono, et al.
Biochemical Pharmacology|November 30, 2023
Melanocortin receptor 4 as a new target in melanoma therapy: Anticancer activity of the inhibitor ML00253764 alone and in association with B-raf inhibitor vemurafenibPaola Orlandi, Marta Banchi, Francesca Vaglini, et al.
Journal of Ethnobiology and Ethnomedicine|May 8, 2007
The importance of a taste. A comparative study on wild food plant consumption in twenty-one local communities in ItalyMaria Pia Ghirardini, Marco Carli, Nicola del Vecchio, et al.
Pageof 6